Analysis and Suggestions for Volume-Based Procurement of General Interventional and Neurosurgical Medical Consumables in the 23 Provincial Alliances

China Health Insurance ›› 2024, Vol. 0 ›› Issue (4) : 20-27.

China Health Insurance ›› 2024, Vol. 0 ›› Issue (4) : 20-27. DOI: 10.19546/j.issn.1674-3830.2024.4.003
Observation & Discussion

Analysis and Suggestions for Volume-Based Procurement of General Interventional and Neurosurgical Medical Consumables in the 23 Provincial Alliances

Author information +
History +

Abstract

This article conducts in-depth research on the background, rules, achievements, advantages, and problems of the centralized procurement project of the 23 provincial alliances for neurosurgical and general interventional medical consumables led by Henan Province. It proposes a moderate centralized procurement strategy from the perspective of rule making, encourages enterprises to participate in centralized procurement and pursue sound development, and reduces hospital operating costs and the burden of the public. Also, it puts forward suggestions for the work that needs to be promoted in centralized procurement later, such as carrying out enough investigation and research, reasonably setting the bottom line, taking price incentives and clinical needs, improving the correlation between price and quality, adhering to “one product, one policy”, improving the informatization, and promoting the health and economic evaluation of centralized procurement, so as to better promote the development of centralized procurement of medical consumables and the reasonable use of medical consumables, providing a reference for high-value medical consumables volume-based procurement in other regions.

Key words

medical consumables / alliance procurement / moderate centralized procurement

Cite this article

Download Citations
Analysis and Suggestions for Volume-Based Procurement of General Interventional and Neurosurgical Medical Consumables in the 23 Provincial Alliances[J]. China Health Insurance. 2024, 0(4): 20-27 https://doi.org/10.19546/j.issn.1674-3830.2024.4.003

References

[1] 国务院办公厅.关于印发治理高值医用耗材改革方案的通知[EB/OL].(2019-07-19)[2023-04-05].https://www.gov.cn/zhengce/content/2019-07/31/content_5417518.htm.
[2] 崔忠付.医链无界——重构中国医院供应链新生态[J].中国物流与采购,2023(07):12.
[3] 国家医疗保障局.关于做好2023年医药集中采购和价格管理工作的通知[EB/OL].(2023-02-22)[2024-01-25].https://www.gov.cn/zhengce/zhengceku/2023-03/02/content_5744059.htm.
[4] 李环,张治国,李程洪,等.我国各省医用耗材集中带量采购政策比较分析[J].中国卫生政策研究,2021,14(03): 48-56.
[5] 河南省医疗保障局.关于通用介入类和神经外科类医用耗材省际联盟采购的公告(四)[EB/OL].(2023-09-02)[2024-02-12].https://ylbz.henan.gov.cn/2023/09-02/2808233.html.
[6] 郑洋洋,丁锦希,李佳明,等.高值医用耗材集中带量采购分配规则的优化设计——兼析有效均衡控价激励效应与临床使用习惯保障关系[J].价格理论与实践, 2020(10): 42-46.
[7] 温晨光.高值医用耗材带量采购制定约定采购量分配规则的实践与思考[J].中国医疗保险, 2021(05):52-56.
[8] 李亚静,王彦泽,张静,等.医用耗材带量采购落地实施存在问题及对策研究[J].经济论坛, 2022(04):147-152.
[9] 孙维阳,高雪,常峰,等.天津高值医用耗材带量采购的实践及经验[J].中国医疗保险,2022(04): 28-32.
[10] 刘清峰,冉净斐.我国高值医用耗材的价格形成与带量采购政策效应研究[J].价格理论与实践, 2021 (02):42-45.
[11] 蒋昌松,张立强,祁鹏,等.带量采购的部分经济学原理解析[J].卫生经济研究,2021,38(06): 63-65.
[12] 谭清立,周芷婷.医用耗材带量采购的医保支付政策研究[J].卫生经济研究,2021,38(11):6-9.

Accesses

Citation

Detail

Sections
Recommended

/